* Mesa Laboratories Inc MLAB.OQ MLAB.O is expected
to show a
rise in quarterly revenue when it reports results on August 3.
* The Lakewood Colorado-based company is expected to report
a
2.8% increase in revenue to $51.85 million from $50.45 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Mesa Laboratories
Inc is
for a loss of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $152.5, above its last closing price of $128.66.
This summary was machine generated August 1 at 18:37 GMT. All
figures in US dollars unless otherwise stated